» Articles » PMID: 38205461

The Perfect Storm: A Case of Rapid-Onset Obesity With Hypoventilation, Hypothalamic, Autonomic Dysregulation, Neuroendocrine Tumor (ROHHADNET) With Heart Failure, Narcolepsy, and a Rare Location of a Pelvic Neuroendocrine Tumor

Overview
Journal Cureus
Date 2024 Jan 11
PMID 38205461
Authors
Affiliations
Soon will be listed here.
Abstract

Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome is a rare disease of concurrent respiratory dysfunction and autonomic dysregulation with endocrine abnormalities. ROHHADNET includes ROHHAD plus coexisting neuroendocrine tumors (NETs). We describe an eight-year-old boy, who originally presented at four years of age with rapid weight gain and hyperhidrosis and who developed mild obstructive sleep apnea (OSA). His clinical course was eventually complicated by hypoxic respiratory failure requiring admission to the pediatric intensive care unit (PICU). Echocardiogram at that time demonstrated dilated cardiomyopathy left ventricular ejection fraction (LVEF) of 28% at time of admission. His respiratory failure persisted despite average volume-assured pressure support (AVAPS) around the clock leading to tracheostomy placement for cardiopulmonary support. He also demonstrated autonomic instability with multiple pituitary hormone deficiencies. Computed tomography (CT) imaging of the abdomen and pelvis demonstrated a presacral soft tissue mass consistent with a tumor of neural crest origin. Daytime somnolence and confusion progressed and a low cerebrospinal fluid hypocretin level revealed a diagnosis of narcolepsy type 1.

Citing Articles

The Enigma That Is ROHHAD Syndrome: Challenges and Future Strategies.

Hawton K, Giri D, Crowne E, Greenwood R, Hamilton-Shield J Brain Sci. 2024; 14(11).

PMID: 39595809 PMC: 11591771. DOI: 10.3390/brainsci14111046.

References
1.
Dhondt K, Verloo P, Verhelst H, Van Coster R, Overeem S . Hypocretin-1 deficiency in a girl with ROHHAD syndrome. Pediatrics. 2013; 132(3):e788-92. DOI: 10.1542/peds.2012-3225. View

2.
Calvo C, Storey C, Morcrette G, Akl P, Freneaux P, Pierron G . Metastatic neuroblastoma in a patient with ROHHAD: A new alert regarding the risk of aggressive malignancies in this rare condition. Pediatr Blood Cancer. 2019; 66(10):e27906. DOI: 10.1002/pbc.27906. View

3.
Harvengt J, Gernay C, Mastouri M, Farhat N, Lebrethon M, Seghaye M . ROHHAD(NET) Syndrome: Systematic Review of the Clinical Timeline and Recommendations for Diagnosis and Prognosis. J Clin Endocrinol Metab. 2020; 105(7). DOI: 10.1210/clinem/dgaa247. View

4.
Chew H, Ngu L, Keng W . Rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation (ROHHAD): a case with additional features and review of the literature. BMJ Case Rep. 2012; 2011. PMC: 3062047. DOI: 10.1136/bcr.02.2010.2706. View

5.
Farooqui Z, Chauhan A . Neuroendocrine Tumors in Pediatrics. Glob Pediatr Health. 2019; 6:2333794X19862712. PMC: 6647200. DOI: 10.1177/2333794X19862712. View